Articles

Survey reveals majority of life-sciences companies lack automated processes

Industry leaders are adopting ‘best of breed’ applications in eClinical stack to speed clinical trials
Written byLloyd Dunlap
| 3 min read

SAN FRANCISCO—Preliminary findings from the goBalto Inc. 2015 Global Study Startup Survey uncovered significant gaps in the industry’s ability to efficiently manage document workflows and activities associated with starting clinical trials.

The survey found that industry leaders were continuing to adopt ‘best of breed’ cloud-based eClinical solutions, such as clinical trial management systems (CTMS), electronic data capture (EDC) and electronic trial master file (eTMF); however, even the latest releases of these applications fell short in addressing one of the most inefficient and costly bottlenecks of clinical trial conduct—study startup (SSU).

The process of initiating clinical trials continues to remain cumbersome, challenging and often behind schedule, making SSU one of the poorest-performing aspects of clinical trials.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D illustration of a single cell surrounded by small molecular particles in a red biological environment.
Measuring mRNA and protein together at single cell resolution can uncover tumor-specific signaling activity and immune features.
Illustration of an antibody intertwined with a DNA double helix.
Discover how CRISPR and single-cell RNA sequencing can connect disease-associated variants to regulatory elements, genes, and pathways.
Digital illustration of the human digestive system highlighting the liver, stomach, and intestines.
Explore how human gut-liver models can improve the translation of preclinical findings into clinical pharmacokinetic predictions.